. Among the group of PTC 70 patients, the prevalence of HT was 24, 2% (17 patients), 15 females (88, 2%) and 2 males (11, 3%), which was higher than the prevalence of HT in other patients without PTC (15,3%), 12 females (92, 3%) and one male (7, 7%). Among of 30 patients with HT prevalence of PTC was 56, 6 % (17 patients), which was higher than the prevalence of PTC in other patients without HT (42,4%). However, there was no statistically significant difference (χ2 =1.98, df=1, p=0.15) between the presence of PTC in specimens with HT and the presence of PTC in other HT negative patients. There was no significant difference in age (Chi-Sq 0, 0005, p=0,18), at the time of diagnosis between PTC patients with and without HT. there is a significant difference in tumor size between patients with or without HT (Chi-Sq 7,800, p=0,02). Prevalence of microcarcinoma was higher in patient with HT than non HT 28,3%, versus 7% with a statistically significant difference (Chi-Sq =7,30 df=1, p=0.006). HT was more often observed in multifocal PTCs than in single PTCs (P=0, 07). Conclusion: In conclusion, the existing data provide inconsistent evidence favoring a causal relationship between HT and PTC. For the moment there is no valid criteria to identify those patients with HT which are at high risk for developing PTC. Careful observation and close follow-up of HT patients with nodular structure is recommended